Laurie Murphy was Appointed as Associate Director, Talent Acquisition at Enanta

Date of management change: July 18, 2019 

What Happened?

Watertown, MA-based Enanta Appointed Laurie Murphy as Associate Director, Talent Acquisition

 

About the Company

Enanta Pharmaceuticals is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs for the treatment of viral infections. Two protease inhibitors, glecaprevir and paritaprevir, discovered and developed through Enanta`s collaboration with AbbVie, have now been approved around the world as part of AbbVie`s regimens for the treatment of hepatitis C virus (HCV) infection. The leading regimen is sold under the tradenames MAVYRET™ (U.S.) and MAVIRET™ (ex-U.S.) (glecaprevir/pibrentasvir). Royalties from the AbbVie collaboration are helping to fund Enanta`s research and development efforts, which are currently focused on the following disease targets: respiratory syncytial virus (RSV), hepatitis B virus (HBV), SARS-CoV-2 (COVID-19) and human metapneumovirus (hMPV).

 

About the Person

Laurie Murphy is Associate Director, Talent Acquisition at Enanta. Previously, Laurie held various senior HR leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Villomann Geanie, Stafne Marcos, Miller Gary, French Jason, Bakardjiev Kristina, Collins Austen, Druley Tiffany, Pollock Chris, jablonski joe, Sheehan Tom, Vuong Karel

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.